[
  {
    "therapeutic_area": "Inflammation",
    "indication": "Crohn's Disease",
    "study_id": "GLPG0634-CL-211",
    "study_name": "Fitzroy FIL CD Trial (Ph. 2)",
    "num_subj_with_gene_exp": 101,
    "num_subj_with_pathway_exp": 101,
    "num_subj_with_biomarkers": 163,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 174
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Ankylosing Spondylitis",
    "study_id": "GLPG0634-CL-223",
    "study_name": "TORTUGA FIL AS Trial (Ph. 2)",
    "num_subj_with_gene_exp": 107,
    "num_subj_with_pathway_exp": 107,
    "num_subj_with_biomarkers": 109,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": true,
    "num_subj_total": 116
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Diabetic Kidney Disease",
    "study_id": "GS-US-223-1015",
    "study_name": "SEL DKD (Ph. 2)",
    "num_subj_with_gene_exp": 0,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 333,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 333
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Ulcerative Colitis",
    "study_id": "GS-US-418-3898 (Cohort A)",
    "study_name": "FIL UC (Ph.3)",
    "num_subj_with_gene_exp": 547,
    "num_subj_with_pathway_exp": 547,
    "num_subj_with_biomarkers": 545,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 547
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Ulcerative Colitis",
    "study_id": "GS-US-418-3898 (Cohort B)",
    "study_name": "FIL UC (Ph.3)",
    "num_subj_with_gene_exp": 539,
    "num_subj_with_pathway_exp": 539,
    "num_subj_with_biomarkers": 538,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 539
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Cutaneous Lupus Erythematosus",
    "study_id": "GS-US-436-4092",
    "study_name": "4092 CLE Trial (Ph. 2)",
    "num_subj_with_gene_exp": 55,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 0,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 55
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Sjogren's Syndrome",
    "study_id": "GS-US-445-4189",
    "study_name": "4185 SjS Trial (Ph. 2)",
    "num_subj_with_gene_exp": 143,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 0,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 143
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Nonalcoholic Steatohepatitis",
    "study_id": "GS-US-454-4378",
    "study_name": "ATLAS NASH Combo Trial (Ph. 2)",
    "num_subj_with_gene_exp": 338,
    "num_subj_with_pathway_exp": 338,
    "num_subj_with_biomarkers": 378,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": true,
    "num_subj_total": 392
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Nonalcoholic Steatohepatitis",
    "study_id": "GS-US-321-0105",
    "study_name": "SIM F3 NASH Trial (Ph. 2)",
    "num_subj_with_gene_exp": 56,
    "num_subj_with_pathway_exp": 56,
    "num_subj_with_biomarkers": 186,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 214
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Nonalcoholic Steatohepatitis",
    "study_id": "GS-US-321-0106",
    "study_name": "SIM F4 NASH Trial (Ph. 2)",
    "num_subj_with_gene_exp": 41,
    "num_subj_with_pathway_exp": 41,
    "num_subj_with_biomarkers": 216,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": true,
    "num_subj_total": 247
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Nonalcoholic Steatohepatitis",
    "study_id": "GS-US-384-1943",
    "study_name": "STELLAR3 SEL F3 NASH Trial (Ph. 3)",
    "num_subj_with_gene_exp": 631,
    "num_subj_with_pathway_exp": 631,
    "num_subj_with_biomarkers": 801,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": true,
    "num_subj_total": 801
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Nonalcoholic Steatohepatitis",
    "study_id": "GS-US-384-1944",
    "study_name": "STELLAR4 SEL F4 NASH Trial (Ph. 3)",
    "num_subj_with_gene_exp": 766,
    "num_subj_with_pathway_exp": 766,
    "num_subj_with_biomarkers": 876,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": true,
    "num_subj_total": 876
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Rheumatoid Arthritis",
    "study_id": "GS-US-417-0301",
    "study_name": "FINCH1 FIL MTX-IR RA Trial (Ph.3)",
    "num_subj_with_gene_exp": 559,
    "num_subj_with_pathway_exp": 559,
    "num_subj_with_biomarkers": 584,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 1755
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Rheumatoid Arthritis",
    "study_id": "GS-US-417-0302",
    "study_name": "FINCH2 RA Trial (Ph. 3)",
    "num_subj_with_gene_exp": 444,
    "num_subj_with_pathway_exp": 444,
    "num_subj_with_biomarkers": 448,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 448
  },
  {
    "therapeutic_area": "Inflammation",
    "indication": "Rheumatoid Arthritis",
    "study_id": "GS-US-417-0303",
    "study_name": "FINCH3 FIL MTX-Na√Øve RA Trial (Ph.3)",
    "num_subj_with_gene_exp": 553,
    "num_subj_with_pathway_exp": 553,
    "num_subj_with_biomarkers": 561,
    "study_has_diff_exp": true,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 1249
  },
  {
    "therapeutic_area": "Oncology",
    "indication": "Gastric Adenocarcinoma",
    "study_id": "GS-US-296-2013",
    "study_name": "Andeca Gastric Adenocarcinoma Trial (Ph. 2)",
    "num_subj_with_gene_exp": 87,
    "num_subj_with_pathway_exp": 87,
    "num_subj_with_biomarkers": 0,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 141
  },
  {
    "therapeutic_area": "Virology",
    "indication": "Hepatitis B Infection",
    "study_id": "GS-US-389-2021",
    "study_name": "",
    "num_subj_with_gene_exp": 0,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 71,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 71
  },
  {
    "therapeutic_area": "Virology",
    "indication": "Hepatitis B Infection",
    "study_id": "GS-US-389-2022",
    "study_name": "",
    "num_subj_with_gene_exp": 0,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 38,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 38
  },
  {
    "therapeutic_area": "Virology",
    "indication": "Hepatitis B Infection",
    "study_id": "GS-US-389-2024",
    "study_name": "",
    "num_subj_with_gene_exp": 0,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 48,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 48
  },
  {
    "therapeutic_area": "Virology",
    "indication": "Hepatitis B Infection",
    "study_id": "GS-US-389-2025",
    "study_name": "",
    "num_subj_with_gene_exp": 0,
    "num_subj_with_pathway_exp": 0,
    "num_subj_with_biomarkers": 0,
    "study_has_diff_exp": false,
    "study_has_pathway_diff_exp": false,
    "num_subj_total": 67
  }
]
